natera.comNatera | Transforming Management of Genetic Disease.

") //-- ") //-- Skip to main content Google Tag Manager Toggle navigation Portal Login Oncology Signatera Residual Disease Test (MRD) Signatera Research Pipeline Signatera Blog Oncology Resource Hub Organ Transplantation Prospera Transplant Assessment Women's Health Horizon Advanced Carrier Screening Panorama Prenatal NIPT Vistara Single-Gene NIPT Anora Miscarriage Test Spectrum Preimplantation Genetics COVID-19 Resources Pricing & Billing About Us Our Story Our People Our Technology Investor Relations Media Careers Contact Us Portal CONTACT CENTER Reach out to one of our therapeutic areas if you have any questions. Natera is here to help at this difficult time. ONCOLOGY +1.650.489.9050 ORGAN TRANSPLANTATION +1.650.273.4468 WOMEN'S HEALTH +1.844.778.4700 GENERAL +1.650.249.9090 New Home Page -- COVID-19 UPDATE Introducing the GI Expanded Access Program for remote Signatera ctDNA testing COVID-19 UPDATE Important lab operations and continuity update COVID-19 UPDATE Important lab operations and continuity update Personalizing cancer care management Custom-built testing for each cancer patient, to detect molecular residual disease (MRD) and help guide treatment decisions. Learn more: Oncology Assessing the health of transplant patients The most precise cell-free DNA (cfDNA) testing in organ transplantation—developed from our trusted legacy. Learn more: Organ Transplantation Planning a family Solutions for all the steps in your journey to parenthood, from starting to plan a family to checking your baby’s health. Learn more: Women's Health OUR CLINICAL EXPERTS Connect with a genetic counselor remotely in your home or office Learn More IN THE NEWS Panorama NIPT achieves 2 million test milestone. Learn More OUR TECHNOLOGY Natera's core technology and finely tuned workflows cut through the noise to deliver superior clinical and analytical performance. Learn More Oncology Organ Transplantation Women's Health Our Story News Careers Contact Us Terms of Use | Privacy Policy | Notice of Privacy Practices Notice of Data Collection for CA Residents Licenses & Certifications The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). Although FDA has exercised enforcement discretion for laboratory-developed tests in the US, certification of the laboratory is required under CLIA to ensure the quality and validity of the tests. CAP accredited, ISO 13485, and CLIA certified. © 2020 Natera, Inc. All Rights Reserved. Drupal is a registered trademark of Dries Buytaert. -- Back to Top...